CN113376079A - Method for analyzing transfection efficiency using CountStar Rigel System in combination with cell staining - Google Patents
Method for analyzing transfection efficiency using CountStar Rigel System in combination with cell staining Download PDFInfo
- Publication number
- CN113376079A CN113376079A CN202110597377.XA CN202110597377A CN113376079A CN 113376079 A CN113376079 A CN 113376079A CN 202110597377 A CN202110597377 A CN 202110597377A CN 113376079 A CN113376079 A CN 113376079A
- Authority
- CN
- China
- Prior art keywords
- cell
- countstar
- rigel
- cells
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- 238000001890 transfection Methods 0.000 title claims abstract description 40
- 238000010186 staining Methods 0.000 title claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims abstract description 94
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 35
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 34
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 34
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical group O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000001514 detection method Methods 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 14
- 239000000872 buffer Substances 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 230000008823 permeabilization Effects 0.000 claims description 2
- 230000009870 specific binding Effects 0.000 claims description 2
- 108020001507 fusion proteins Proteins 0.000 abstract description 12
- 102000037865 fusion proteins Human genes 0.000 abstract description 12
- 238000001814 protein method Methods 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 7
- 230000007547 defect Effects 0.000 abstract description 4
- 238000005520 cutting process Methods 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 8
- 238000000684 flow cytometry Methods 0.000 description 7
- 102000034287 fluorescent proteins Human genes 0.000 description 7
- 108091006047 fluorescent proteins Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000007447 staining method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003260 vortexing Methods 0.000 description 3
- 230000002411 adverse Effects 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- -1 FITC compound Chemical class 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a method for analyzing transfection efficiency by using a CountStar Rigel system in combination with cell staining, which comprises the following steps: 1) cell staining of the transfected cell samples using CloneDetect reagent; the CloneDetect reagent can be specifically combined with proteins produced by cells and secreted to the cell surface; 2) detecting the cell sample stained in the step 1) by using a CountStar Rigel system, and reading a FITC signal to obtain the transfection efficiency of the transfected cell sample. The method has the characteristics of quickly, simply and accurately obtaining the result of the transfection efficiency, can overcome the defects of time and labor waste and difficulty in subsequent cutting in the fusion protein method, has better accuracy than the GFP cell method, and has the advantages of simplified operation and improved efficiency compared with a fluorescence microscope or a flow cytometer.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a method for detecting transfection efficiency of mammalian cell plasmid DNA by using a CountStar Rigel system in combination with cell staining.
Background
Currently, the method of analyzing transfection efficiency is usually to use a fluorescent protein to label or indicate the target protein. This method can be classified into the following two methods. The first method is a fusion protein method, in which a fluorescent protein and a target protein are expressed as a fusion protein, and the expression level of the fluorescent protein is directly related to the expression level of the target protein. However, in the expression and production of pharmaceutical proteins, it is not permissible for the pharmaceutical protein to carry a fluorescent protein, since the subsequent cleavage is time-consuming, laborious and difficult, which adversely affects the quality and cost of the pharmaceutical protein. The second method is GFP cell-based comparison, which is to express fluorescent protein and target protein separately and independently according to the same transfection method, and then to compare the ratio of fluorescent protein to the transfection efficiency of target protein. This type of approach is an indirect approach, since the fluorescent protein is usually not the same size and structure as the target protein, and thus the transfection efficiency is different, and the drawback of directly comparing the two is that it causes a large error.
The prior art solution that can be used to detect the fluorescent signal of cells is to use fluorescence microscopy or flow cytometry. The fluorescence microscope uses ultraviolet rays as a light source to irradiate an object to be detected, so that the object to be detected emits fluorescence, and then the shape and the position of the object to be detected are observed under the microscope. It is used for researching the absorption and transportation of substances in cells, the distribution and positioning of chemical substances and the like. These substances may be those which fluoresce when irradiated with ultraviolet rays, or those which do not fluoresce but fluoresce when irradiated with ultraviolet rays after being stained with a fluorescent dye or a fluorescent antibody. The fluorescent microscope has the defects of manual adjustment during observation, extremely low efficiency and large manpower requirement. Fluid cytometers are devices for the automated analysis and sorting of cells which rapidly measure, store and display a series of important biophysical, biochemical characteristic parameters of dispersed cells suspended in a liquid, and from which a given cell subpopulation can be sorted according to a preselected parameter range. In the flow cytometry, fluorescence generated by a cell stained by fluorescence after being excited by a suitable light is measured by converting the fluorescence into an electrical signal by a photoelectric converter. Flow cytometers are carefully adjusted before and even during use to ensure reliability and optimization of operation. The flow cytometer has the disadvantages of high price, complex operation, high difficulty in handling, professional training of operators and great adverse effect on experimental results due to non-professional operation.
CountStar Rigel is a novel automatic instrument designed by ALIT Life Sciences, is based on image detection, is matched with multiple fluorescence channels, and carries out quantitative analysis by collecting cell information in an image. The fluorescence microscopic imaging and the analysis of the statistical population are integrated, not only can provide statistical data of the cell population, but also can obtain an image of a single cell, thereby providing morphological information of the cell, and simultaneously displaying cell images and analysis results of cell viability, apoptosis, transfection, period and the like on a display screen. The system is specifically optimized for analysis of primary cells in peripheral blood, including PBMCs, CAR-T, NK cells and MSCs commonly used in cell therapy. The automatic control system is high in automation degree and simple and convenient to operate, results can be known immediately by only one key, and the price is obviously lower than that of a flow cytometer. The cell staining method currently used by CountStar Rigel for transfection efficiency is still the two methods described above, namely the fusion protein method and the GFP cell-specific method.
Disclosure of Invention
The technical problem to be solved by the invention is to provide a novel method for analyzing the transfection efficiency, which has the characteristics of quickly, simply and accurately detecting and obtaining the result of the transfection efficiency, can overcome the defects of time and labor waste and difficulty in subsequent cutting in a fusion protein method, has better accuracy than a GFP cell comparison method, and has the advantages of simplified operation, convenient use and efficiency improvement compared with a fluorescence microscope or a flow cytometer.
In order to solve the technical problems, the invention provides the following technical scheme:
a method for analyzing transfection efficiency using the CountStar Rigel system in conjunction with cell staining, the method comprising the steps of:
1) cell staining of the transfected cell samples using CloneDetect reagent; the CloneDetect reagent can be specifically combined with a protein produced by cells and secreted to the surfaces of the cells, and the CloneDetect reagent has a fluorescent group;
2) detecting the cell sample stained in the step 1) by using a CountStar Rigel system, and reading a FITC signal to obtain the transfection efficiency of the transfected cell sample.
Specifically, in the step 1), the specific binding means that the CloneDetect reagent is specifically bound to the Fc terminal or the light chain terminal of a drug protein produced by cells and secreted to the cell surface.
Specifically, in the step 1), the CloneDetect reagent is an antibody protein.
Specifically, in the step 1), the fluorescent group is a fluorescein isothiocyanate group.
Specifically, in the step 1), the method for staining the cells is as follows: resuspending the transfected cell sample with CloneDetect reagent and incubating at room temperature for 20-60 min; and then washing the cells for 1-3 times by using a permeabilization buffer solution, and then washing the cells for 1-3 times by using a PBS buffer solution to obtain a cell sample which is dyed.
Preferably, the obtained cell sample after complete staining is resuspended in PBS buffer, preserved at 0-4 ℃ and used for detection by CountStar Rigel system.
Preferably, the storage time does not exceed 1 hour.
Specifically, in the step 2), a sample of the stained cells is sampled and added to the well of the slide of the CountStar Rigel system, and the "GFP transfection efficiency" mode using the CountStar Rigel system is selected for reading the FITC signal.
Specifically, in the step 2), the transfection efficiency results are displayed on the screen of the CountStar Rigel system.
In particular, the method is used to characterize the expression of a drug protein in a cell sample.
The invention develops a new method for analyzing the transfection efficiency by combining a CountStar Rigel system with a CloneDetect reagent cell staining technology, and the method can quickly, simply and accurately detect and obtain the result of the transfection efficiency.
In the two cell staining methods for detecting the transfection efficiency in the prior art, the fusion protein is difficult to cut, or the error is large, and the transfection efficiency of the target protein to the host cell cannot be directly measured, and the transfection efficiency of the target protein to the host cell is deduced by the transfection efficiency of the fusion protein or GFP protein in an indirect mode.
In the prior art, the commonly used fluorescence microscope has low cost and low efficiency and needs a large amount of manpower. The fluid cytometer has high cost, complex operation and high training requirement on operators, and many laboratories have no use condition. Therefore, both approaches have great limitations for more efficient development of stable cell lines, shortening of the development cycle of biopharmaceuticals, and reduction of the development cost of biopharmaceuticals.
CloneDetect reagent was used in the method of the present invention to stain transfected cells. The reagent is an antibody protein which can be specifically combined with the Fc end or the light chain end of a drug protein, and a fluorescent group, such as a FITC compound (fluorescein isothiocyanate) which can emit light, is connected with the antibody protein. The FITC signal emitted by the fluorophore can be detected and read. If the cell sample produces a drug protein and is secreted to the cell surface, the drug protein will be specifically bound by the CloneDetect reagent, thereby causing the drug protein on the cell surface to produce a FITC signal. While no signal is detectable by cells that do not produce the drug protein. Transfection efficiency can be obtained by calculating the proportion of cells with signal. The production of the CloneDetect reagent is animal-origin-free and meets the safety requirements of pharmaceutical production on the reagent. The agent is only loosely contacted with the drug protein and the cell itself for a short period of time and does not require additional cleavage after purification. The specific combination of the reagent and the drug protein is that after the drug protein is expressed, a small part of sample is taken and analyzed by the reagent, the dyeing is a non-covalent bond connection and is reversible, and the reagent can be dissociated by changing the substrate concentration and other conditions. More importantly, the drug protein was not stained by the reagent except for the sample. The fusion protein method is to express the fusion protein and the drug protein at the same time, and permanently connect them by covalent bond, and can only cut by consuming energy after the final drug purification, such as using hydrolytic enzyme. This is one of the significant advantages of the method of the invention over the fusion protein method.
The CloneDetect reagent involved in the invention is designed by Molecular Devices and is used for the own ClonePix systemTMAnd reagents of the CloneMedia system to improve workflow productivity for screening and selecting mammalian cell lines. The following is an introduction to the range of applications of the product: 1. selection of a detection agent specific for a secreted mouse, rat or human IgG; 2. when detecting antigen-specific secretion of hybridomas, complex starter factor products can be used; 3. the provided tissue culture was verified to be sterile and azide-free; 4. for ready-to-use "spray" applications in atomizer spray heads. In general, the CloneDetect reagent, which is generally used to measure protein secretion in single cells for the purpose of screening high expressing cell clones, rather than to measure transfection efficiency, has never been used in the CountStar novel instrument.
The method provided by the invention provides a scheme for combining a CountStar Rigel system with a CloneDetect reagent, can overcome the defects of time and labor consumption of subsequent cutting in a fusion protein method, has better accuracy than a GFP cell method, has the advantages of high automation degree, no need of manually adjusting focal length and high detection efficiency compared with a fluorescence microscope, and has the advantages of low cost, simplicity in operation, convenience in use and efficiency improvement compared with a flow cytometer.
Drawings
FIG. 1 shows the fluorescence signal from the CountStar Rigel system of example 1.
FIG. 2 shows the results of the analysis of CountStar Rigel system in example 1 using FCS Expression De Novo software.
FIG. 3 shows the results of the CountStar Rigel system of test 1 in example 2.
FIG. 4 shows the results of the transfection efficiency measured by the flow cytometer of test 1 in example 2.
FIG. 5 shows the results of the CountStar Rigel system of test 2 in example 2, analyzed using FCS Expression De Novo software.
FIG. 6 shows the results of the transfection efficiency measured by the flow cytometer of test 2 in example 2.
Detailed Description
The technical solutions of the present invention will be described clearly and completely below, and it should be apparent that the described embodiments are some, but not all, embodiments of the present invention. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
Example one
1. Cell staining
Reagent:
reagent 1.CloneDetect (Molecular device, product No. K8295 or K8205)
Reagent 2. intracellular fixing and permeabilizing buffer kit (thermo fisher scientific, product No. 88-8824-00)
Reagent 3 PBS buffer (thermo fisher scientific, product No. 10010023)
The method comprises the following steps:
A. cell staining process
1. 1 × E6 cells were collected in a 1.7ml centrifuge tube.
2. Spin at 350G for 5 min and remove the supernatant.
3. Wash with 0.7ml PBS and mix gently by vortexing. The supernatant was discarded.
4. Add 500. mu.L of IC fixation buffer in reagent 2 and mix with pulsed vortex to fix the cells.
5. Incubate at room temperature for 20-60 minutes. And (4) avoiding light.
6. 0.7mL of one-fold permeation buffer was added and centrifuged at 400x g for 5 minutes at room temperature. The supernatant was discarded.
7. And 6, repeating the step.
8. Buffer permeabilized with one fold in reagent 2 at 1: CloneDetect was diluted at a ratio of 200.
9. The cell pellet was resuspended in 100. mu.L of diluted CloneDetect.
10. Incubate at room temperature for 20-60 minutes. And (4) avoiding light.
11. One-fold permeation buffer in 0.7ml reagent 2 was added and centrifuged at 400x g for 5 minutes at room temperature. The supernatant was discarded.
12. Step 11 is repeated. Mix gently by vortexing.
13. Wash twice with 1ml PBS buffer and mix gently by vortexing.
14. The stained cells were resuspended in an appropriate volume of PBS buffer.
15. The samples were stored in a refrigerator at 4 degrees celsius until the signal was read. Not more than 1 hour.
2. Signal reading with CountStar
Description of the apparatus: CountStar Rigel is a novel image-based automated cellular analysis platform with a full-spectrum fluorescence microscope, FCS Expression De Novo software, which can analyze and report data and images. A plurality of fluorescence channels are provided, different fluorescence can be analyzed, and dyes with different wavelengths can be supported. The method is simple and convenient to operate, user-friendly, free of manual focal length adjustment and high in stability and accuracy.
Step (ii) of
1. Take 20. mu.l of surface stained cells to wells of a CountStar slide.
2. The "GFP transfection efficiency" mode of CountStar Rigel was chosen for reading FITC signal.
3. The location of the sample well is selected.
4. The sample name and cell type are entered.
5. The corresponding fluorescence channel is selected. Adjust 'gain' and exposure time.
6. Clicking the "start" button
7. The results of the transfection rate read are displayed on the screen, the results are shown in FIG. 1, and the instrument automatically gives a result that 94% of the cells have fluorescent signals. The raw data can also be exported and analyzed by FCS De Novo software results are shown in FIG. 2, the left panel in FIG. 2 shows all morphologically healthy and intact cells in black boxes, and the right panel shows that 94.28% of these healthy cells show GFP + with a fluorescence signal, i.e., 94.28% transfection efficiency.
The above process basically does not need manual debugging after the detection parameters are selected, and the detection efficiency is high. The detection is carried out according to the flow, the detection of a transfected cell sample can be completed in only 3 minutes, and the detection of 20 samples per hour can be completed on average when a large number of samples are used. While the prior flow cytometer combined with the fusion protein method/GFP cell comparison method only takes 2 minutes to run samples, the cleaning and debugging steps are generally required to be started for 30 minutes additionally before each use, a cleaning step of 30 minutes is additionally required after the use is finished, and 20 samples are detected in the same way, and the total time is 1 hour and 40 minutes.
Example 2
The method of the invention has a detection accuracy level that is substantially consistent with flow cytometry detection. Flow cytometry can become a detection method generally accepted at present, and is based on the advantage of accuracy. The method of the invention finds that the experimental result is very close to that of the flow cytometer by comparison. The settings for the comparative experiments were as follows:
test 1: the samples were transfected HEK293 cells. Sampling 1, and analyzing the transfection efficiency by adopting a CountStar Rigel system provided by the invention and combining a GFP cell type ratio method; and 2, sampling, namely detecting the transfection efficiency by combining the conventional flow cytometry with a GFP cell comparison method, wherein the operation flow is carried out according to the operation recommended by equipment manufacturers. The results of the detection are shown in FIGS. 3 and 4.
In FIG. 3, sample 1 shows a GFP + data of 38.68% at CountStar; in FIG. 4, sample 2 showed 32.3% GFP + data on a loss-of-cell cytometer. Considering the systematic error of the two instruments themselves, we consider the two data to be very close in accuracy.
Test 2: the samples were transfected CHO cells. Sampling 3, and analyzing the transfection efficiency by adopting a CountStar Rigel system provided by the invention and combining a cell staining method; and 4, sampling, and detecting the transfection efficiency by adopting the conventional flow cytometry combined with a cell staining method, wherein the operation flow is carried out according to the operation recommended by equipment manufacturers. The detection results are shown in fig. 5 and 6.
In FIG. 5, sample 3 showed 12.04% CHO cell transfection efficiency after CountStar output data was treated with FCS De Novo software; in FIG. 6, sample 4 showed 10.2% CHO cell transfection efficiency on a flow cytometer. Considering the systematic error of the two instruments themselves, we consider these two data to be very close in accuracy.
The above two examples were tested with two different types of cells, respectively, where the only variable controlled in the test was the instrument difference, and the test results both showed similar results for the method of the present invention and the flow cytometer, indicating that both reached very similar levels of detection accuracy. And the method of the invention has significant advantages in detection efficiency and cost input compared with the flow cytometry.
In summary, the above embodiments are merely preferred embodiments of the present invention, and are not intended to limit the scope of the present invention, and any modifications, equivalents, improvements, etc. made within the spirit and principle of the present invention should be included in the scope of the present invention.
Claims (10)
1. A method for analyzing transfection efficiency using the CountStar Rigel system in conjunction with cell staining, comprising the steps of:
1) cell staining of the transfected cell samples using CloneDetect reagent; the CloneDetect reagent can be specifically combined with a protein produced by cells and secreted to the surfaces of the cells, and the CloneDetect reagent has a fluorescent group;
2) detecting the cell sample stained in the step 1) by using a CountStar Rigel system, and reading a FITC signal to obtain the transfection efficiency of the transfected cell sample.
2. The method of claim 1, wherein in step 1), the specific binding is that the CloneDetect reagent specifically binds to the Fc terminus or the light chain terminus of a drug protein produced by cells and secreted to the cell surface.
3. The method of claim 2, wherein in step 1), the CloneDetect reagent is an antibody protein.
4. The method of claim 1, wherein in step 1), the fluorophore is a fluorescein isothiocyanate group.
5. The method of claim 1, wherein in step 1), the method of staining the cells is: resuspending the transfected cell sample with CloneDetect reagent and incubating at room temperature for 20-60 min; and then washing the cells for 1-3 times by using a permeabilization buffer solution, and then washing the cells for 1-3 times by using a PBS buffer solution to obtain a cell sample which is dyed.
6. The method of claim 5, wherein the stained cell sample is resuspended in PBS buffer and stored at 0-4 ℃ for detection by the CountStar Rigel system.
7. The method of claim 6, wherein the holding time is no more than 1 hour.
8. The method of claim 1, wherein in step 2), a sample of stained cells is sampled and applied to a well of a slide of a CountStar Rigel system, and the reading of the FITC signal is selected using the "GFP transfection efficiency" mode of the CountStar Rigel system.
9. The method of claim 8, wherein in step 2), the transfection efficiency results are displayed on a screen of a CountStar Rigel system.
10. The method of any one of claims 1 to 9, wherein the method is used to characterise the expression of a pharmaceutical protein in a cell sample.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110597377.XA CN113376079B (en) | 2021-05-31 | 2021-05-31 | Method for analyzing transfection efficiency by using CountStar Rigel system in combination with cell staining |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110597377.XA CN113376079B (en) | 2021-05-31 | 2021-05-31 | Method for analyzing transfection efficiency by using CountStar Rigel system in combination with cell staining |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113376079A true CN113376079A (en) | 2021-09-10 |
| CN113376079B CN113376079B (en) | 2024-07-16 |
Family
ID=77574879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110597377.XA Active CN113376079B (en) | 2021-05-31 | 2021-05-31 | Method for analyzing transfection efficiency by using CountStar Rigel system in combination with cell staining |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113376079B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117078621A (en) * | 2023-08-15 | 2023-11-17 | 深圳太力生物技术有限责任公司 | Cell strain stability determination method, device, computer equipment and storage medium |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080267486A1 (en) * | 2007-03-02 | 2008-10-30 | Invitrogen Corporation | Methods for selecting cells with enhanced growth and production properties |
| US20150268249A1 (en) * | 2012-09-14 | 2015-09-24 | Molecular Devices, Llc | Method of selecting a monoclonal cell colony |
| CN111781375A (en) * | 2020-07-08 | 2020-10-16 | 上海科医联创医学检验所有限公司 | Immune negative fluorescent staining method for rapidly identifying non-expression antigen cells |
| CN112540039A (en) * | 2020-12-31 | 2021-03-23 | 北京博奥体质宝健康科技有限公司 | Method for directly calculating number of adherent living cells |
| US20220162560A1 (en) * | 2019-01-31 | 2022-05-26 | Beijing Cytoniche Biotechnology Co., Ltd. | Three-dimensional culture method for large-scale preparation of stem cells |
-
2021
- 2021-05-31 CN CN202110597377.XA patent/CN113376079B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080267486A1 (en) * | 2007-03-02 | 2008-10-30 | Invitrogen Corporation | Methods for selecting cells with enhanced growth and production properties |
| US20150268249A1 (en) * | 2012-09-14 | 2015-09-24 | Molecular Devices, Llc | Method of selecting a monoclonal cell colony |
| US20220162560A1 (en) * | 2019-01-31 | 2022-05-26 | Beijing Cytoniche Biotechnology Co., Ltd. | Three-dimensional culture method for large-scale preparation of stem cells |
| CN111781375A (en) * | 2020-07-08 | 2020-10-16 | 上海科医联创医学检验所有限公司 | Immune negative fluorescent staining method for rapidly identifying non-expression antigen cells |
| CN112540039A (en) * | 2020-12-31 | 2021-03-23 | 北京博奥体质宝健康科技有限公司 | Method for directly calculating number of adherent living cells |
Non-Patent Citations (3)
| Title |
|---|
| 朱欣颖;刘欣;王兴兵;汪安友;汪敏;刘纳纳;游凤涛;潘桂芳;杨林;: "靶向CD7的嵌合抗原受体NK-92MI细胞对CD7阳性血液系统恶性肿瘤细胞的杀伤作用", 中国实验血液学杂志, no. 04 * |
| 王大宁;刘亚静;郑清炳;李智海;范飞;柳欣林;宋硕;顾颖;夏宁邵;李少伟;: "悬浮驯化HEK-293FT细胞表达人乳头瘤病毒16型假病毒及其冷冻电镜结构解析", 病毒学报, no. 05 * |
| 邓晓芬;杨晓佳;易天红;冯英;柯潇;赖维莉;: "融合蛋白基因与抗体基因电转染CHO-S细胞的条件摸索优化", 生物技术通报, no. 04, pages 229 - 234 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117078621A (en) * | 2023-08-15 | 2023-11-17 | 深圳太力生物技术有限责任公司 | Cell strain stability determination method, device, computer equipment and storage medium |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113376079B (en) | 2024-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6592822B1 (en) | Multi-analyte diagnostic system and computer implemented process for same | |
| US11726031B2 (en) | Fluorescent spectrum correcting method and fluorescent spectrum measuring device | |
| Jaroszeski et al. | Fundamentals of flow cytometry | |
| CN108693100B (en) | Flow cytometer and particle detection method | |
| Radcliff et al. | Basics of flow cytometry | |
| WO2014133160A1 (en) | Urine sample analysis device and urine sample analysis method | |
| CN108398361B (en) | Method for predicting blood disease outcome by using erythrocyte DNA damage signal and application thereof | |
| WO2020133635A1 (en) | Fully automatic sperm cell detector | |
| CN112161913A (en) | Analysis method and equipment for flow type fluorescence analysis system | |
| CN113376079B (en) | Method for analyzing transfection efficiency by using CountStar Rigel system in combination with cell staining | |
| WO2022019006A1 (en) | Information processing system and information processing method | |
| Pierzchalski et al. | Introduction A: Recent advances in cytometry instrumentation, probes, and methods | |
| Simonson et al. | Creating virtual hematoxylin and eosin images using samples imaged on a commercial CODEX platform | |
| US20080182290A1 (en) | Apparatus and methods for determining viability of cell-based products | |
| Nitta et al. | Cellaca® PLX image cytometer as an alternative for immunophenotyping, GFP/RFP transfection efficiencies, and apoptosis analysis | |
| WO2023171463A1 (en) | Information processing device and information processing system | |
| CN212459331U (en) | Time-resolved flow type fluorescence detection and analysis device | |
| Drápela et al. | High-Throughput, Parallel Flow Cytometry Screening of Hundreds of Cell Surface Antigens Using Fluorescent Barcoding | |
| Staaf et al. | Molecular diffusion in plasma membranes of primary lymphocytes measured by fluorescence correlation spectroscopy | |
| JP2000157298A (en) | Analyzing of chromosomal abnormality and apparatus | |
| US20240053250A1 (en) | Threshold gating for flow cytometry methods | |
| Papenfuss | Flow cytometry and immunophenotyping in drug development | |
| WO2008065529A2 (en) | Apparatus and methods for determining viability of cell-based products | |
| CN111239029A (en) | Time-resolved flow type fluorescence detection analysis device and use method thereof | |
| Hochsprung et al. | Upgrading urinalysis to support the goals of healthcare reform. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20230417 Address after: Building 6, Building 22, Building 28, No. 356 Zhengbo Road, Fengxian District, Shanghai, 2014 Applicant after: Shanghai Bibo Biomedical Engineering Co.,Ltd. Address before: Room 207, No. 199, GuoShouJing Road, Pudong New Area, Shanghai 201203 Applicant before: Shanghai Bibo Biomedical Technology Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |